Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-08-10

Clinical Trial Update: Clinical Trial to Evaluate the Antihypertensive Effect of AGSCT101 in Patient With Hypertension [Phase 3]

View source ↗

Summary

A phase 3 clinical trial is evaluating the antihypertensive effect of AGSCT101 in patients with essential hypertension. The current trial status is not disclose…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AGSCT101

Snippet

Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd | Conditions: Essential Hypertension | Phase 3 | Status: UNKNOWN